Bioactivity and safety of B7‐H3‐targeted chimeric antigen receptor T cells against anaplastic meningioma
Xin Tang(Sichuan University), Liangxue Zhou(University of Electronic Science and Technology of China), Gang Guo(Shihezi University), Yuelong Wang(Huaqiao University), Aiping Tong(Chengdu Medical College), Shuangming Fan(Sichuan University), Shan Wang(Chinese Academy of Sciences), Caiying Jiang(Affiliated Hospital of Youjiang Medical University for Nationalities), Fujun Liu(Sichuan University), Hongjian Li(Sichuan University), Zhiyong Liu(Sichuan University), Meijia Yang, Jianguo Xu(West China Hospital of Sichuan University), Meijun Zheng(Sichuan University), Yating Hu(Sichuan University), Zongliang Zhang(Sichuan University), Shasha Zhao(Tongji University), Hui Yang(Sichuan University), Gaowei Li(Sichuan University), Yi Cao(Sichuan University)
Cited by 75
Related Papers
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity
|Nature|2020|849
A Review of Graph Neural Networks and Their Applications in Power Systems
|Journal of Modern Power Systems and Clean Energy|2022|387
B7-H3 as a Novel CAR-T Therapeutic Target for Glioblastoma
|Molecular Therapy — Oncolytics|2019|215
CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint
|Nature Communications|2020|188